Key result
Low haemoglobin on admission linked to ~8.3-fold higher risk of no-reflow after primary PCI.
Why the study?
The accuracy of low haemoglobin level in predicting the no-reflow phenomenon in patients undergoing primary PCI was not established.
Does low haemoglobin (<11.5 g/dL) predict the no-reflow phenomenon in patients with acute STEMI undergoing primary percutaneous coronary intervention?
Cross-Sectional (n=115)
No
Does low haemoglobin (<11.5 g/dL) predict the no-reflow phenomenon in patients with acute STEMI undergoing primary percutaneous coronary intervention?
Low haemoglobin at admission (<11.5 g/dL) is a highly specific but poorly sensitive independent predictor of the no-reflow phenomenon in patients undergoing primary PCI for acute STEMI.
Answers are grounded in this paper and cite their sources.
Low haemoglobin was associated with no-reflow after primary PCI in STEMI; hypothesis-generating and requires prospective validation before clinical use.
Objective: To determine the accuracy of low haemoglobin level in predicting the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention. Study Design: Cross-sectional analytical study Place and Duration of Study: Armed Forces Institute of Cardiology and National Institute of Heart Diseases (AFIC/NIHD), Rawalpindi, Pakistan from Dec 2024 to May 2025. Methodology: A total of 115 patients aged 30-70 years, regardless of gender, with acute STEMI undergoing PPCI were enrolled through consecutive sampling. Post-coronary artery bypass graft (CABG) patients, those who had received glycoprotein IIb/IIIa inhibitors before the procedure, patients presenting beyond 24 hours of symptom onset, with chronic kidney disease, and with a history of major bleeding or haemorrhagic disorders were excluded. Low haemoglobin was defined as <11.5 g/dL. The no-reflow phenomenon was described as TIMI flow grade <3. Results: Among 115 patients [105(91.3%) male; median age 57.00(51.00–62.00) years], no-reflow was observed in 30(26.1%) patients. Patients with low haemoglobin (<11.5 g/dL) experienced higher no-reflow than with normal haemoglobin (p=0.018). The sensitivity and specificity were 16.7% and 97.6%, respectively, with a positive predictive value (PPV) of 71.4%, a negative predictive value (NPV) of 76.8%, and an overall diagnostic accuracy of 76.5%. Conclusion: Low haemoglobin level demonstrated high specificity but poor sensitivity in predicting the no-reflow phenomenon following PPCI.
No takes yet. Share an insight, caveat, or question.
Nazir et al. (2026) conducted a cross-sectional in Acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) (n=115). Low haemoglobin (<11.5 g/dL) vs. Normal haemoglobin (≥11.5 g/dL) was evaluated on No-reflow phenomenon (TIMI flow grade <3) (OR 8.30, 95% CI 1.15-45.42, p=0.01). Low haemoglobin upon admission was associated with a higher risk of the no-reflow phenomenon after primary percutaneous coronary intervention, demonstrating high specificity but poor sensitivity.
Synapse has enriched 10 related papers. Consider them for comparative context: